NCT03767842 (VIGOR) is a clinical trial of Visor System in Stroke, Acute, sponsored by Cerebrotech Medical Systems, Inc..

Who is sponsoring NCT03767842?

NCT03767842 is sponsored by Cerebrotech Medical Systems, Inc..

What drugs are being tested in NCT03767842?

Interventions in NCT03767842: Visor System.

What condition does NCT03767842 study?

NCT03767842 studies Stroke, Acute.

Is NCT03767842 still recruiting?

NCT03767842 is currently status unknown. Last updated 7 December 2018.

Last reviewed 2018-12-07 · How we verify

NCT03767842: VIGOR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Volumetric Impedance to Guide Stroke Response

Status unknown Last updated 7 December 2018

What this trial tests

trial testing Visor System in Stroke, Acute in 316 participants. Status unknown.

Timeline

18 July 2018

Primary endpoint
31 March 2019

31 March 2019

Quick facts

Lead sponsor	Cerebrotech Medical Systems, Inc.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	316
Start date	18 July 2018
Primary completion	31 March 2019
Estimated completion	31 March 2019
Sites	1 location across United States

Drugs / interventions tested

Visor System

Conditions studied

Stroke, Acute — all drugs for Stroke, Acute →

Sponsor

Cerebrotech Medical Systems, Inc.

Who can join

18 and older, any sex, with Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the ability of the Visor System to detect hemispheric bioimpedance asymmetry

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke, Acute

Currently open trials in the same condition.

NCT06825897 — Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiograp · NA · recruiting
NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
NCT07253870 — Comperative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation in Subacute Stroke Patients · NA · recruiting
NCT06941753 — Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge · NA · recruiting
NCT06123650 — Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia. · NA · recruiting

Other Cerebrotech Medical Systems, Inc. trials

Trials by the same sponsor.

NCT03148340 — Volumetric Integral Phase-shift Spectroscopy for Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Acute Br · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03767842 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cerebrotech Medical Systems, Inc.
Last refreshed: 7 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing